Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1996-6-11
pubmed:abstractText
Neuroleptics are considered the mainstay of treatment in Tourette's disorder, and haloperidol is deemed the treatment of choice by many. Factors such as treatment efficacy and the side effects that appear in response to neuroleptic administration have been implicated in affecting medication compliance. However, a detailed evaluation of these factors has yet to be undertaken in Tourette's disorder.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0160-6689
pubmed:author
pubmed:issnType
Print
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
129-35
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:8617698-Adolescent, pubmed-meshheading:8617698-Adult, pubmed-meshheading:8617698-Affect, pubmed-meshheading:8617698-Affective Symptoms, pubmed-meshheading:8617698-Age of Onset, pubmed-meshheading:8617698-Akathisia, Drug-Induced, pubmed-meshheading:8617698-Antipsychotic Agents, pubmed-meshheading:8617698-Child, pubmed-meshheading:8617698-Drug Administration Schedule, pubmed-meshheading:8617698-Fear, pubmed-meshheading:8617698-Female, pubmed-meshheading:8617698-Haloperidol, pubmed-meshheading:8617698-Humans, pubmed-meshheading:8617698-Male, pubmed-meshheading:8617698-Middle Aged, pubmed-meshheading:8617698-Patient Compliance, pubmed-meshheading:8617698-Patient Dropouts, pubmed-meshheading:8617698-Patient Education as Topic, pubmed-meshheading:8617698-Psychiatric Status Rating Scales, pubmed-meshheading:8617698-Tourette Syndrome, pubmed-meshheading:8617698-Treatment Refusal
pubmed:year
1996
pubmed:articleTitle
Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives.
pubmed:affiliation
Department of Psychiatry, New York University School of Medicine, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.